InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-7.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by William Arsani, Director. Director active across 1 company, notably Design Therapeutics, Inc.. Aggregated, 6 disclosures have been published. Split: 4 buys · 1 sell. Total volume traded: €5.2m. Activity tracked since 31 August 2021. The latest transaction was filed on 9 August 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
814,874 shares@ US$4.2561.1% of flowCommon StockSEC:0001415889-24-021086:0
1,217,627 sharesCommon StockSEC:0001209191-23-048441:0
275,000 shares@ US$2.1510.5% of flowCommon StockSEC:0001209191-23-047773:0
Ideal exit: 24 May 2024 (T+270)
25,000 shares@ US$18.98720.048% mcap29.1% of flowCommon StockSEC:0001209191-22-020638:0
Ideal exit: 16 Dec 2022 (T+270)
40,000 shares@ US$15.450.058% mcap35.4% of flowCommon StockSEC:0001209191-21-054492:0
Ideal exit: 28 May 2022 (T+270)
40,000 shares@ US$15.4510.1% of flowCommon StockSEC:0001209191-21-054492
Ideal exit: 28 May 2022 (T+270)
6 of 6 declarations
About William Arsani
William Arsani is a Board Member at Design Therapeutics, Inc. In this role, he participates in overseeing the company's activities and making strategic decisions. William brings his expertise to guide the direction of Design Therapeutics and ensure compliance with governance standards. His commitment to operational excellence is a valuable asset to the board.
